Chiesi USA, Inc. FDA Record
- Latest inspection NAI · Aug 26, 2026
- Last warning letter 2010
Chiesi USA, Inc. has 5 FDA recalls, 9 inspections, 0 510(k) clearances and 3 compliance actions on record. FDA has issued 3 warning letters to Chiesi USA, Inc., the most recent on Jun 22, 2010.
- Latest recall
- D-0838-2026 · Class III · Aug 19, 2026
- Latest inspection
- Aug 26, 2026 · NAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 5 | Nov 11, 2026 (checked Nov 15, 2026, unchanged) | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 9 | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 3 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Chiesi USA, Inc.: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 1 | 0 | 0 | 3 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 2 | 0 |
| 2018 | 1 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 |
Reviewing Chiesi USA, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Chiesi USA, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Chiesi USA, Inc. FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Jun 22, 2010 · Record page | |||
| Nov 13, 2009 · Record page | |||
| May 4, 2009 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0838-2026 | Class III | Revcovi (elapegademase-lvlr) Injection, 2.4mg/1.5mL (1.6 mg/mL), Single-Dose Vial, Rx Only, For… | Aug 19, 2026 |
| D-0689-2026 | Class II | CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only… | Jul 6, 2026 |
| D-0402-2026 | Class II | CUROSURF (poractant alfa), 240 mg, Intratracheal Suspension, 3L Single-dose-Vial, Rx only, Chiesi… | Mar 17, 2026 |
| D-1341-2019 | Class II | ZYFLO CR (zileuton) extended-release tablets, 600 mg, 120-count bottles, Rx only, Distributed by… | May 31, 2019 |
| D-1342-2019 | Class II | Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco… | May 31, 2019 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Aug 26, 2026 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Aug 1, 2024 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Jun 15, 2018 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Mar 6, 2015 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Mar 4, 2015 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Sep 20, 2012 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Jul 24, 2012 | Cary, NC | Drugs | No Action Indicated (NAI) | 3006389494 |
| Mar 24, 2010 | Cary, NC | Drugs | Official Action Indicated (OAI) | 3006389494 |
| Apr 28, 2009 | Cary, NC | Drugs | Voluntary Action Indicated (VAI) | 3006389494 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 3 compliance actions under Chiesi USA, Inc.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3006389494 | Cary, NC | 9 | Aug 26, 2026 |
Chiesi USA, Inc. and the FDA: common questions
Has Chiesi USA, Inc. received an FDA warning letter?
Yes. FDA has issued 3 warning letters to Chiesi USA, Inc.. The most recent is dated Jun 22, 2010.
Has Chiesi USA, Inc. received an FDA Form 483?
FDA has not published a Form 483 for "Chiesi USA, Inc." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Chiesi USA, Inc.?
The most recent FDA inspection on file ended Aug 26, 2026 at Cary, NC and was classified NAI. FDA has 9 inspections of Chiesi USA, Inc. on file, 1 of them classified OAI (official action indicated).
Has Chiesi USA, Inc. had an FDA recall?
Yes. Chiesi USA, Inc. has 5 FDA recalls on record. The most recent started Aug 19, 2026.
Need more than this page shows? Ask about Chiesi USA, Inc. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.